Trial Profile
Effectiveness and safety assessment of add-on therapy of perampanel for epilepsy patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 07 Oct 2018 Status changed from recruiting to completed.
- 10 Apr 2017 New trial record